Long-Term Follow Up Study of Subjects Previously Administered HMI 102

ID#: NCT04348708

Age: 18 - 55 years

Gender: All

Healthy Subjects: No

Recruitment Status: Enrolling by invitation

Start Date: August 30, 2020

End Date: December 01, 2026

Summary: An Open-Label, Long-Term Follow Up Study of Safety and Efficacy in PKU Subjects with PAH Deficiency Previously Administered HMI 102
Eligibility:

Inclusion Criteria:

- Subject was previously administered HMI 102.

- Subject is able to understand the purpose and risks of the study and is willing to provide informed consent.

- Subject is able to comply with all study procedures and long-term follow-up.

Exclusion Criteria:

- Participation in the study is not in the subject's best interest, in the opinion of the Investigator.
Find a Clinical Trial